Company profile
Antlia Bioscience company profile
Antlia Bioscience develops peptide-based therapies to treat cardiovascular and metabolic diseases.
Business identity
- Website
- https://antliabio.com/
- Contact email
- [email protected]
- Phone number
- 619-990-0290
- Operating status
- Active
- Company type
- For Profit
- Founded
- 2020-01-01
Headquarters
- Headquarters
- Encinitas, California, United States
- Country code
- US
- Continent
- North America